Multimodal Physiologic State Intelligence Study | MicrobiomeTrials← Back to trialsNCT07814118
Multimodal Physiologic State Intelligence Study
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-09-02Est. Completion: 2046-09-02
Enrollment target: 25,000 participants Locations- Truway Health, Inc., New York, New York, United States
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Heart Failure
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety…
Fairhope, United StatesEst. completion Nov 2027
Recruiting
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Calgary, CanadaEst. completion May 2012